These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 22730797)

  • 1. [Emergency of synthetic drugs in the general landscape of addiction].
    Karila L
    Rev Prat; 2012 May; 62(5):661-3. PubMed ID: 22730797
    [No Abstract]   [Full Text] [Related]  

  • 2. [Synthetic drugs: the new low-cost landscape of drugs].
    Karila L; Petit A; Cottencin O; Coscas S; Reynaud M
    Rev Prat; 2012 May; 62(5):664-6. PubMed ID: 22730798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploratory comparative study on the diffusion of synthetic cannabinoids and synthetic cathinones.
    Arfken CL; Owens D; Madeja C; DeAngelis C
    J Psychoactive Drugs; 2014; 46(5):362-8. PubMed ID: 25364986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alarm over synthetic cannabinoids.
    Underwood E
    Science; 2015 Jan; 347(6221):473. PubMed ID: 25635070
    [No Abstract]   [Full Text] [Related]  

  • 5. Some new psychoactive substances: precursor chemicals and synthesis-driven end-products.
    Collins M
    Drug Test Anal; 2011; 3(7-8):404-16. PubMed ID: 21755608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxicology and management of novel psychoactive drugs.
    Kersten BP; McLaughlin ME
    J Pharm Pract; 2015 Feb; 28(1):50-65. PubMed ID: 25261428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New trends in the cyber and street market of recreational drugs? The case of 2C-T-7 ('Blue Mystic').
    Schifano F; Deluca P; Agosti L; Martinotti G; Corkery JM; Alex B; Caterina B; Heikki B; Raffaella B; Anna C; Lucia DF; Dorte DR; Magi F; Susana F; Irene F; Claude G; Lisbet H; Lene SJ; Mauro L; Christopher L; Aino M; Teuvo P; Milena P; Salman R; Damien R; Angela RM; Francesco R; Norbert S; Holger S; Josep T; Marta T; Francesco Z;
    J Psychopharmacol; 2005 Nov; 19(6):675-9. PubMed ID: 16272191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case series of 21 synthetic cathinones abuse.
    Batisse A; Fortias M; Bourgogne E; Grégoire M; Sec I; Djezzar S
    J Clin Psychopharmacol; 2014 Jun; 34(3):411-3. PubMed ID: 24743721
    [No Abstract]   [Full Text] [Related]  

  • 9. [Drug Dependence and Cytotoxicity of Law-evading Drugs: Their Identities Explored from Basic Research].
    Funada M
    Yakugaku Zasshi; 2016; 136(1):65-72. PubMed ID: 26725670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The NBOMe series: a novel, dangerous group of hallucinogenic drugs.
    Ninnemann A; Stuart GL
    J Stud Alcohol Drugs; 2013 Nov; 74(6):977-8. PubMed ID: 24172126
    [No Abstract]   [Full Text] [Related]  

  • 11. Present situation and trends of illegal drug traffic and addiction in the world.
    Bayer I
    Ther Hung; 1987; 35(1):3-7. PubMed ID: 3438862
    [No Abstract]   [Full Text] [Related]  

  • 12. Age, period, and cohort effects in synthetic cannabinoid use among US adolescents, 2011-2015.
    Keyes KM; Rutherford C; Hamilton A; Palamar JJ
    Drug Alcohol Depend; 2016 Sep; 166():159-67. PubMed ID: 27491817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The behavioral profile of spice and synthetic cannabinoids in humans.
    Müller HH; Kornhuber J; Sperling W
    Brain Res Bull; 2016 Sep; 126(Pt 1):3-7. PubMed ID: 26548494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new stimulant of abuse: 5-(2-aminopropyl)indole.
    Coppola M; Mondola R
    Am J Psychiatry; 2013 Feb; 170(2):226. PubMed ID: 23377642
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardiotoxicity associated with the synthetic cannabinoid, K9, with laboratory confirmation.
    Young AC; Schwarz E; Medina G; Obafemi A; Feng SY; Kane C; Kleinschmidt K
    Am J Emerg Med; 2012 Sep; 30(7):1320.e5-7. PubMed ID: 21802885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute reactions to drugs of abuse.
    Med Lett Drugs Ther; 1996 May; 38(974):43-6. PubMed ID: 8628181
    [No Abstract]   [Full Text] [Related]  

  • 17. Arylethylamine psychotropic recreational drugs: a chemical perspective.
    Freeman S; Alder JF
    Eur J Med Chem; 2002 Jul; 37(7):527-39. PubMed ID: 12126772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A "krokodil" emerges from the murky waters of addiction. Abuse trends of an old drug.
    Katselou M; Papoutsis I; Nikolaou P; Spiliopoulou C; Athanaselis S
    Life Sci; 2014 May; 102(2):81-7. PubMed ID: 24650492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed seizure-like activity following analytically confirmed use of previously unreported synthetic cannabinoid analogues.
    Schep LJ; Slaughter RJ; Hudson S; Place R; Watts M
    Hum Exp Toxicol; 2015 May; 34(5):557-60. PubMed ID: 25233895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug Use Among Young People.
    Carter D
    Am J Nurs; 2015 Dec; 115(12):20. PubMed ID: 26600347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.